1. R-1929
2. R1929
3. Stresnil
1. 1649-18-9
2. Azaperon
3. Stresnil
4. Suicalm
5. Fluoperidol
6. Eucalmyl
7. Azeperone
8. Sedaperone Vet
9. R-1929
10. Azaperona
11. Azaperonum
12. Nsc 170976
13. 1-butanone, 1-(4-fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-
14. 1-(4-fluorophenyl)-4-(4-pyridin-2-ylpiperazin-1-yl)butan-1-one
15. 1-(3-(4-fluorobenzoyl)propyl)-4-(2-pyridyl)piperazine
16. R 1929
17. 4'-fluoro-4-(4-(2-pyridyl)-1-piperazinyl)butyrophenone
18. 1-(4-fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-1-butanone
19. Nsc-170976
20. Azaperone For Veterinary Use
21. 1-(4-fluorophenyl)-4-(4-(pyridin-2-yl)piperazin-1-yl)butan-1-one
22. 1-butanone, 1-(4-fluorophenyl)-4-(4-(2-pyridinyl)-1-piperazinyl)-
23. Mls003106751
24. 19bv78ak7w
25. Chembl340211
26. Chebi:88301
27. 1-(4-fluorophenyl)-4-[4-(pyridin-2-yl)piperazin-1-yl]butan-1-one
28. Mfcd00866692
29. Nsc170976
30. Ncgc00016590-01
31. Azaperone 100 Microg/ml In Acetonitrile
32. Butyrophenone, 4'-fluoro-4-[4-(2-pyridyl)-1-piperazinyl]-
33. Cas-1649-18-9
34. Dsstox_cid_25361
35. Dsstox_rid_80826
36. Dsstox_gsid_45361
37. 4'-fluoro-4-[4-(2-pyridyl)-1-piperazinyl]butyrophenone
38. Azaperonum [inn-latin]
39. 1-(4-fluorophenyl)-4-(4-(2-pyridinyl)-1-piperazinyl)-1-butanone
40. Butyrophenone, 4'-fluoro-4-(4-(2-pyridyl)-1-piperazinyl)-
41. Azaperona [inn-spanish]
42. Smr001233462
43. Ccris 1586
44. Sr-05000001712
45. Einecs 216-715-8
46. Brn 0565491
47. Unii-19bv78ak7w
48. Azaperone [usan:usp:inn:ban]
49. Stresnil (tn)
50. 1-one
51. Azaperone (usp/inn)
52. Azaperone [inn]
53. Azaperone [mi]
54. Azaperone [usan]
55. Prestwick0_001117
56. Prestwick1_001117
57. Prestwick2_001117
58. Prestwick3_001117
59. Spectrum2_001250
60. Spectrum3_001966
61. Azaperone [mart.]
62. Azaperone [usp-rs]
63. Bspbio_001254
64. Bspbio_003566
65. 5-23-03-00041 (beilstein Handbook Reference)
66. Mls002154163
67. Schembl121134
68. Spectrum1505332
69. Spbio_001160
70. Spbio_003117
71. Azaperone [green Book]
72. Bpbio1_001379
73. Azaperone [usp Impurity]
74. Dtxsid2045361
75. Kbio3_002914
76. Azaperone [usp Monograph]
77. Lamotrigine 5-n-?-d-glucuronide
78. Hms1571o16
79. Hms1922d20
80. Hms2090k03
81. Hms2093d03
82. Hms2098o16
83. Hms2230c17
84. Hms3369i10
85. Hms3652d15
86. Hms3715o16
87. Hms3885f11
88. Pharmakon1600-01505332
89. 1-(4-fluorophenyl)-4-[4-(2-pyridyl)piperazin-1-yl]butan-1-one
90. Bcp12176
91. Hy-b1470
92. Zinc2596977
93. Tox21_110512
94. Azaperone 100 Microg/ml In Ethanol
95. Bbl011031
96. Bdbm50036733
97. Ccg-39158
98. Nsc758969
99. Pdsp1_000828
100. Pdsp2_000815
101. S4219
102. Stk802185
103. Akos005622715
104. Tox21_110512_1
105. Am84563
106. Cs-5158
107. Db11376
108. Ks-5204
109. Nsc-758969
110. Ncgc00016590-02
111. Ncgc00016590-03
112. Ncgc00016590-04
113. Ncgc00016590-06
114. Ncgc00016590-08
115. Ncgc00095171-01
116. Ncgc00095171-02
117. Ncgc00095171-03
118. Sy067157
119. Sbi-0206748.p001
120. Wln: T6n Dntj D3vr Df& A- Bt6nj
121. Ab00514057
122. Ft-0602908
123. Sw196387-3
124. Azaperone, Vetranal(tm), Analytical Standard
125. A16416
126. C73189
127. D02620
128. Ab00514057-06
129. Ab00514057_07
130. 649a189
131. A810604
132. L000791
133. J-010171
134. Q4832244
135. Sr-05000001712-1
136. Sr-05000001712-3
137. Brd-k45861246-001-05-0
138. Brd-k45861246-001-08-4
139. Azaperone, British Pharmacopoeia (bp) Reference Standard
140. {4'-fluoro-4-[4-(2-pyridyl)-1-piperazinyl]butyrophenone}
141. 4'-fluoro-4-[4-(2-pyridinyl)-1-piperazinyl]butyrophenone
142. Azaperone, European Pharmacopoeia (ep) Reference Standard
143. 1-(4-fluorophenyl)-4-(4-pyridin-2-ylpiperazin-1-yl)butan-
144. Azaperone, United States Pharmacopeia (usp) Reference Standard
145. Butyrophenone, {4'-fluoro-4-[4-(2-pyridyl)-1-piperazinyl]-}
146. 1-(4-fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-1-butznone
147. 1-butanone,1-(4-fluorophenyl)-4-(4-(2-pyridinyl)-1-piperazinyl)-
148. 1-(4-fluorophenyl)-4-[4-(2-pyridyl)piperazin-1-yl]butan-1-one;azaperone
149. 1-butanone, {1-(4-fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-}
150. 1-(4-fluoro-phenyl)-4-(4-pyridin-2-yl-piperazin-1-yl)-butan-1-one(azaperone)
Molecular Weight | 327.4 g/mol |
---|---|
Molecular Formula | C19H22FN3O |
XLogP3 | 3.3 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 6 |
Exact Mass | 327.17469050 g/mol |
Monoisotopic Mass | 327.17469050 g/mol |
Topological Polar Surface Area | 36.4 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 390 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
Dopamine Antagonists
Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)
Hypnotics and Sedatives
Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)
LOOKING FOR A SUPPLIER?